Selected article for: "acute respiratory syndrome and macrophage cell"
Author: Das, Undurti N.
Title: Can Bioactive Lipid Arachidonic Acid Prevent and Ameliorate COVID-19?
  • Cord-id: uesry4z7
  • Document date: 2020_8_19
    • ID: uesry4z7
    Snippet: It is proposed that the bioactive lipid, arachidonic acid (AA, 20:4 n-6), can inactivate severe acute respiratory syndrome(SARS-CoV-2), facilitate M1 and M2 macrophage generation, suppress inflammation, prevent vascular endothelial cell damage, and regulate inflammation resolution processes based on the timely formation of prostaglandin E2 (PGE2) and lipoxin A4 (LXA4) based on the context. Thus, AA may be useful both to prevent and manage coronavrus disease-2019(COVID-19).
    Document: It is proposed that the bioactive lipid, arachidonic acid (AA, 20:4 n-6), can inactivate severe acute respiratory syndrome(SARS-CoV-2), facilitate M1 and M2 macrophage generation, suppress inflammation, prevent vascular endothelial cell damage, and regulate inflammation resolution processes based on the timely formation of prostaglandin E2 (PGE2) and lipoxin A4 (LXA4) based on the context. Thus, AA may be useful both to prevent and manage coronavrus disease-2019(COVID-19).

    Search related documents:
    Co phrase search for related documents
    • aa administration and acute respiratory syndrome: 1
    • aa arachidonic acid and aa deficiency: 1, 2
    • aa arachidonic acid and aa similar: 1
    • aa arachidonic acid and acute respiratory distress syndrome: 1
    • aa arachidonic acid and acute respiratory syndrome: 1, 2, 3, 4
    • aa arachidonic acid and adipose tissue: 1
    • aa similar and acute respiratory distress syndrome: 1
    • aa similar and acute respiratory syndrome: 1, 2, 3
    • abnormal activation and acute respiratory distress syndrome: 1, 2
    • abnormal activation and acute respiratory syndrome: 1, 2, 3, 4
    • abnormality common and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7